Geary Richard S Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
59
Insider Sells Sum
$18.81M

Insider Activity of Geary Richard S

According to the SEC Form 4 filings, Geary Richard S, being in a position of

  1. EVP, Chief Development Officer at Ionis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 33839 shares for $2.56M,
    over all time since 2009-01-02, has bought 0 shares, and sold 616967 shares for $30.25M.

Biography of Geary Richard S

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$2,561,8082100

Comparison of Insiders on Amount of Buys and Sells

2025-11-06SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
33,038
0.0212%
$75.72$2.5M+0.3%
2025-11-05SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
801
0.0005%
$75.01$60,083-0.5%
2025-11-03SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
905
0.0006%
$75.05$67,924+0.9%
2025-10-31SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
54,664
0.0345%
$75.11$4.11M+0.03%
2025-09-30SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
57,900
0.0362%
$65.24$3.78M+13.59%
2025-09-02SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
10,000
0.0055%
$50.37$503,671+29.25%
2025-08-05SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
10,000
0.0062%
$42.86$428,593+72.61%
2025-01-31SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
1,406
0.0009%
$32.40$45,561+33.28%
2025-01-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
7,072
0.0045%
$32.86$232,407+29.55%
2024-08-29SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
331
0.0002%
$49.63$16,428-28.05%
2024-08-28SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
320
0.0002%
$49.16$15,731-27.1%
2024-08-05SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
2,430
0.0017%
$48.00$116,640-23.61%
2024-02-02SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
1,995
0.0013%
$50.04$99,836-17.35%
2024-01-17SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
7,338
0.005%
$50.42$369,960-18.42%
2023-12-21SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
4,112
0.0029%
$49.29$202,681-12.97%
2023-12-20SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
6,500
0.0046%
$49.64$322,643-11.56%
2023-12-14SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
10,613
0.0074%
$49.58$526,236-14.03%
2023-02-06SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
1,920
0.0013%
$40.66$78,070+1.9%
2023-01-18SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Officer
7,873
0.0055%
$39.57$311,525+2.76%
2021-01-13SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chief Development Offc
141
<0.0001%
$59.50$8,390-37.35%
Total: 66
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.